| Literature DB >> 22615684 |
M Shahlaei1, A Fassihi, L Saghaie, E Arkan, A Pourhossein.
Abstract
BACKGROUND AND PURPOSE OF THE STUDY: A quantitative structure activity relationship (QSAR) model based on artificial neural networks (ANN) was developed to study the activities of 29 derivatives of 3-amino-4-(2-(2-(4-benzylpiperazin-1-yl)-2-oxoethoxy) phenylamino) cyclobutenedione as C-C chemokine receptor type 1(CCR1) inhibitors.Entities:
Keywords: PCA; Quantitative Structure Activity Relationship; feed-forward ANN; inhibitory activity
Year: 2011 PMID: 22615684 PMCID: PMC3304395
Source DB: PubMed Journal: Daru ISSN: 1560-8115 Impact factor: 3.117
The structures and biological activities of compounds
| Compound | R1 | Observed p | Predicted p |
| 1 | 7.585 | 7.802 | |
| 2 | 6.455 | 6.321 | |
| 3 | 7.107 | 7.125 | |
| 4 | 6.568 | 6.628 | |
| 5 | 7.013 | 7.117 | |
| 6 | 5.630 | 5.739 | |
| 5.536 | 5.234 | ||
| 8 | 6.657 | 6.661 |
Figure 1The first two components (PC1, and PC2) from the principal component analysis of the 29 studied molecules.
Figure 3Optimization of number of neurons in hidden layer (A), momentum (B), and, Learning rate (C).
Figure 4Calculated vs. experimental activity of the investigated compounds in training and test sets…
Various statistical parameter for developed PC- ANN model
| Training set | 0.906 | 0.189 | 0.752 | −0.102 | −0.102 | 1.001 | 0.997 | 0.630 |
| Test Set | 0.932 | 0.103 | 0.388 | −0.072 | −0.070 | 1.003 | 0.994 | 0.690 |
R 2=Square Regression coefficient
RMSE=Root mean square error
PRESS=predicted error sum of square for training set
Structures and details of the proposed molecules as novel CCR15 inhibitors.
| Compound | R | Predicted pIC50 |
| S1 | 8.112 | |
| S2 | 8.082 | |
| S3 | 7.962 | |
| S4 | 8.004 |
The structures and biological activities of compounds 9–13
| Compound | R2 | R3 | Observed p | Predicted p |
| 9 | H | H | 6.036 | 6.012 |
| 10 | H | Br | 7.602 | 7.243 |
| H | F | 6.795 | 6.462 | |
| 12 | H | Me | 7.045 | 7.001 |
| 13 | F | F | 6.853 | 7.192 |
The structures and biological activities of compounds 14–27
| Compound | R4 | Observed p | Predicted p |
| 14 | Et | 7.142 | 7.118 |
| 15 | Pr | 6.769 | 7.097 |
| 16 | CH2Ph | 6.096 | 6.083 |
| 17 | H | 8.000 | 7.976 |
| 18 | 6.795 | 6.786 | |
| 19 | 7.200 | 7.203 | |
| 7.698 | 7.970 | ||
| 21 | 7.744 | 7.693 | |
| 22 | 7.193 | 7.192 | |
| 23 | 7.920 | 7.713 | |
| 24 | 7.301 | 7.273 | |
| 25 | 7.823 | 7.426 | |
| 26 | 7.376 | 6.794 | |
| 27 | 7.585 | 7.798 |
The structures and biological activities of compounds 28–29
| Compound | R5 | Observed p | Predicted p |
| 28 | H | 8.154 | 8.248 |
| 29 | Me | 7.119 | 7.285 |
pIC50=−log(IC50)
Compounds selected as test set
The result of of principal component analysis on the total descriptors.
| Component | Eigenvalues | % of Variance Explained | Cumulative% |
|---|---|---|---|
| 1 | 470.394 | 39.495 | 39.495 |
| 2 | 138.563 | 11.634 | 51.130 |
| 3 | 127.783 | 10.729 | 61.859 |
| 4 | 79.828 | 6.702 | 68.561 |
| 5 | 61.826 | 5.191 | 73.752 |
| 6 | 42.604 | 3.577 | 77.330 |
| 7 | 36.975 | 3.104 | 80.434 |
| 8 | 34.61 | 2.906 | 83.340 |
| 9 | 30.600 | 2.569 | 85.910 |
| 10 | 23.659 | 1.986 | 87.896 |
| 11 | 18.673 | 1.567 | 89.464 |
| 12 | 17.002 | 1.427 | 90.892 |
| 13 | 14.264 | 1.197 | 92.089 |
| 14 | 13.344 | 1.120 | 93.210 |